Last reviewed · How we verify

NCT05555173

IVs With Buzzy in Chronic Pain Patients

Withdrawn NA Last updated 24 February 2026
What this trial tests

NA trial testing Buzzy in Chronic Pain. Withdrawn.

Timeline
1 October 2022
Primary endpoint
20 October 2023
20 October 2023

Quick facts

Lead sponsorSteward St. Elizabeth's Medical Center of Boston, Inc.
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposeprevention
Start date1 October 2022
Primary completion20 October 2023
Estimated completion20 October 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Steward St. Elizabeth's Medical Center of Boston, Inc.

Who can join

18 and older, any sex, with Chronic Pain or Acute Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators are conducting a study to compare the effectiveness of the Buzzy® device with that of no pain relief method for IV placement in adults with chronic pain receiving lidocaine infusions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Buzzy

Trials testing the same drug.

Other recruiting trials for Chronic Pain

Currently open trials in the same condition.

Other Steward St. Elizabeth's Medical Center of Boston, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05555173.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing